Tackling an Evolving Pandemic

RAND's Jennifer Bouey will discuss RAND’s rapid COVID-19 response, including insights and analysis to help strengthen and safeguard communities, rethink and retool institutions, and determine the best ways forward.

Join us here for this conversation on October 22nd at 10:00 a.m. PT / 1:00 p.m. ET.

The novel coronavirus, first detected in late 2019, continues to cause widespread illness and death, economic devastation, and long-term uncertainty throughout the world. As we look toward 2021, what can we expect?

In this video conversation, Jennifer Bouey will discuss RAND’s rapid COVID-19 response, including insights and analysis to help strengthen and safeguard communities, rethink and retool institutions, and determine the best ways forward. She will talk about what we’ve learned, and what the coming months might bring as the crisis continues to unfold and evolve. Brandon Baker hosts.

Learn More

COVID-19 Pandemic: Insights from RAND
Apr 10, 2020

RAND research and expertise can inform immediate policy responses to address the disastrous effects of COVID-19—and help aid in recovery long after the disease stops spreading.
Who Would Benefit from a Successful Chinese COVID-19 Vaccine?
Aug 12, 2020
Jennifer Bouey @BoueyHuang

China, one of the world's largest producers of vaccines, could be among the first to produce one for COVID-19. If that happens, then would China be able to produce sufficient doses for domestic use? And which other countries would likely benefit?
COVID-19 Screening in the Workplace
Sep 17, 2020
Courtney A. Gidengil @c_gidengil, Shira H. Fischer @ShiraFischer, et al.

Workplaces are checking for COVID-19 symptoms verbally, with a paper form or app, with onsite temperature checks, or by combining these approaches. Which methods are likely to detect infection and help employees feel safer? And which are safe, feasible, and least problematic in terms of privacy?
China's Health System Reform and Global Health Strategy in the Context of COVID-19
May 7, 2020
Jennifer Bouey @BoueyHuang

In response to SARS, China restructured its public health system in 2004. It has also prioritized health care system reforms over the past decade. What are the implications of these developments on China's response to COVID-19? And how can the United States engage China in global pandemic response?